CompletedPhase 2/3

Low Salt Diet in Idiopathic Hypercalciuria

Italy210 participantsStarted 2005-01

Plain-language summary

Randomized clinical trial comparing water therapy plus low-salt diet to water therapy alone in patients affected by idiopathic calcium nephrolithiasis. Treatment duration: three months Primary end-point: correction of hypercalciuria Main inclusion criteria: calcium stone formers with idiopathic hypercalciuria, with at least one stone expelled and analyzed by infrared spectrophotometry; presence of hypercalciuria (\>300 mg/day in males and \>200 mg/day in females); 18-65 years. Main exclusion criteria: primary hyperparathyroidism, primary hyperoxaluria, enteric hyperoxaluria, bowel resection, inflammatory bowel disease, renal tubular acidosis, sarcoidosis, sponge kidney, hyperthyroidism, use of hypercalciuric drugs such as Vitamin D, acetazolamide, anti-epileptic drugs

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Main inclusion criteria: * idiopathic calcium stone formers, with at least one stone expelled and analyzed by infrared spectrophotometry; presence of hypercalciuria (\>300 mg/day in males and 20 mg/day in females); * 18-65 years. Main exclusion criteria: * primary hyperparathyroidism, * primary hyperoxaluria, * enteric hyperoxaluria, * bowel resection, * inflammatory bowel disease, * renal tubular acidosis, * sarcoidosis, sponge kidney, * hyperthyroidism, * use of hypercalciuric drugs such as Vitamin D, * acetazolamide, * anti-epileptic drugs

What they're measuring

Normalization of urinary calcium levels

Trial details

NCT IDNCT01005082

SponsorUniversity of Parma

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2008-09

View on ClinicalTrials.gov More Hypercalciuria trials